AnteoTech Flags Sales Conversion As Key Task After Revenue Falls
ADO: $0.017 +6.25% · MC: $56M
At its 2026 AGM, AnteoTech said converting its customer pipeline into sales is its top priority after FY2026 revenue fell to about $468,000 from about $969,000, partly because a Serum Institute shipment shifted into July. The company reported cash expenses down 19% and ended the year with $11 million in cash and no debt; it also highlighted battery and diagnostics progress, including Ultranode 95 testing and ongoing customer evaluations. All AGM resolutions were passed.

Comments